FDA Approved: LAMIVUDINE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for lamivudine by Apotex Corp., indicating a labeling-related change under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Viral Hepatitis

Drugs mentioned

• Lamivudine (lamivudine)

Snippet

SUPPL AP for LAMIVUDINE (LAMIVUDINE)